Kim Lyerly, MD
MD, University of California at Los Angeles
Telli ML, Nagata H, Wapnir I, Acharya CR, Zablotsky K, Fox BA, et al. Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy. Clin Cancer Res. 2021 Feb 16;
Wang J, Osada T, Morse MA, Calzone F, Yan H, Thai D, et al. Targeting the glucagon receptor signaling pathway as a novel strategy to counteract PI3K inhibitor induced hyperglycemia while sustaining tumor PI3K inhibition. Leuk Lymphoma. 2021 Feb 12;1–6.
Crosby EJ, Nagata H, Telli ML, Acharya CR, Wapnir I, Zablotsky K, et al. Intratumoral delivery of tavokinogene telseplasmid (plasmid IL-12) and electroporation induces an immune signature that predicts successful combination in patients. In: Cancer Research. 2021.